Tennessee, Arkansas & Mississippi (TAM)
Cardiovascular Clinical ConsortiumThe Vascular Biology Center of Excellence maintains a regional clinical trial network that includes clinicians, scientists and supporting staff in Tennessee, Arkansas and Mississippi. The network enables tri-state cardiologists to participate in multi-center clinical trials and research sub-studies that focus on coronary artery disease. This network includes physicians, scientists, physician scientists and research coordinators in the regional area of Tennessee, Arkansas and Mississippi. Hence, the designation TAM Cardiovascular Network.
The advantages of a clinical trial network are copious. First, it establishes a presence within the tri-state area in the cardiovascular arena. Regional efforts in the diagnosis and treatment in cardiovascular disease are often under represented and not fully recognized. Second, it permits our network clinicians to participate in more multi-center trials and therefore access to state-of-the-art pharmaceuticals for Mid South patients. Third, it sets the stage for investigator-initiated studies that will have an impact on the treatment and diagnostic strategies for cardiovascular diseases. Finally, the TAM Network gives investigators the opportunity to participate with little effort in clinical trials and sub-studies, bacause we are able to provide additional laboratory support not typically available in clinical laboratories. Through joint efforts, there is a greater opportunity for investigators to co-author abstracts and manuscripts and, if interested, to participate in speaker's series and seminars. For more information please contact the TAM Associate Director, Mary Jacoski.
[HOME] [CENTER] [DIRECTOR] [FACULTY] [WORKING GROUP] [INJURY LAB] [TAM]
[TAM INVESTIGATORS] [TAM TRIALS] [NEWS] [GIVING]
